Skip to main content
. Author manuscript; available in PMC: 2022 Dec 19.
Published in final edited form as: Biomater Sci. 2022 Dec 6;10(24):6951–6967. doi: 10.1039/d2bm01113a

Figure 6. Response of human macrophages to celastrol treatment.

Figure 6.

Human monocyte-derived MF were subject to LPS activation (100 ng/mL) and celastrol treatment at varying doses (1–10 μM). The expression of both M1-associated (A) and M2-associated (B) genes is presented as gene counts relative to untreated (M0) controls; M1 controls (red) are included for reference.